Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 8/20 | 0.55 |
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.44 |
| ▸ | F9 | P00740 | 1/20 | 0.42 |
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | PLAU | P00749 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 5/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11748001 | 0.88 | SLC6A9 (0.50) | SLC6A4GSRSLC6A2SLC6A3CYP1A2 | |
| SCHEMBL14967332 | 0.87 | SLC6A4 (0.53) | SLC6A4GSRSLC6A2SLC6A3KCNK2 | |
| SCHEMBL11750036 | 0.87 | SLC6A4 (0.60) | SLC6A4GSR | |
| SCHEMBL11754821 | 0.87 | SLC6A4 (0.60) | SLC6A4GSRSLC6A2SLC6A3KCNK2 | |
| SCHEMBL11750911 | 0.87 | SLC6A4 (0.60) | SLC6A4GSRSLC6A2SLC6A3KCNK2 | |
| SCHEMBL3976067 | 0.87 | SLC6A9 (0.52) | SLC6A4GSRSLC6A2SLC6A3KCNK2 | |
| Acrylic Acid SCHEMBL27803176 | 0.86 | GSR (0.45) | SLC6A4GSRKDM4EMEN1ALOX15 | |
| SCHEMBL14967119 | 0.84 | SRD5A2 (0.53) | SLC6A4GSRHRH3TSHRKMT2A | |
| SCHEMBL28137895 | 0.83 | SLC6A4 (0.61) | SLC6A4SLC6A2SLC6A3KCNK2KCNH2 | |
| SCHEMBL11755613 | 0.82 | SLC6A4 (0.56) | SLC6A4GSRSLC6A2SLC6A3KCNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109880062-A | A kind of cross-linkable solidifying material and its continuous production method | 广东博兴新材料科技有限公司 | 2019-06-14 | — | — | CN | claimed |
| CN-109876858-A | One kind preparation method of (methyl) acrylate substance and the application of 2- acrylamide-2-methyl propane sulfonic | 广东博兴新材料科技有限公司 | 2019-06-14 | — | — | CN | claimed |
| CN-109776312-A | A kind of preparation method of acryloxy propionic ester type compound | 衡阳师范学院 | 2019-05-21 | — | — | CN | claimed |
| CN-109734586-A | Treatment method for recycling (methyl) acrylic acid in esterification reaction system | 广东博兴新材料科技有限公司 | 2019-05-10 | — | — | CN | claimed |
| CN-106699523-A | Synthetic method of o-phenyl phenoxyethanol | 上海飞凯光电材料股份有限公司 | 2017-05-24 | — | — | CN | claimed |
| CN-102070415-B | Method for preparing o-phenylphenoxyethanol | SHANGHAI JINSHAN CHEMICAL CO LTD | 2013-07-10 | — | — | CN | claimed |
| CN-102070415-A | Method for preparing o-phenylphenoxyethanol | SHANGHAI JINSHAN CHEMICAL CO LTD | 2011-05-25 | — | — | CN | claimed |
| CN-117362162-A | Preparation method of carbonyl compound | 中国科学院大连化学物理研究所 | 2024-01-09 | — | — | CN | disclosed |
| CN-117004958-A | Fine-washing phosphorus-free degreasing powder for aluminum-iron-zinc co-tank, and preparation method and application thereof | 湖南金裕环保科技有限公司 | 2023-11-07 | — | — | CN | disclosed |
| US-20200102323-A1 | ACC INHIBITORS AND USES THEREOF | SCHRÖDINGER, INC. | 2020-04-02 | — | — | US | disclosed |
| US-10472374-B2 | ACC inhibitors and uses thereof | GILEAD APOLLO, LLC (US) | 2019-11-12 | — | — | US | disclosed |
| EP-3329919-B1 | ACC INHIBITORS AND USES THEREOF | GILEAD APOLLO LLC (US) | 2019-11-06 | — | — | EP | disclosed |
| CN-109880062-A | A kind of cross-linkable solidifying material and its continuous production method | 广东博兴新材料科技有限公司 | 2019-06-14 | — | — | CN | disclosed |
| US-20090138208-A1 | IMMUNOGLOBULIN G BINDING POCKET | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2009-05-28 | — | — | US | disclosed |
| US-20060014735-A1 | Use of urea variants as affinity ligands | CYTIVA BIOPROCESS R&D AB (SE) | 2006-01-19 | — | — | US | disclosed |
| US-6743820-B2 | ADMINISTERING TO THE EPITHELIUM AN EFFECTIVE AMOUNT OF AN AGENT COMPRISING: A) AT LEAST ONE AROMATIC GROUP; B) AT LEAST ONE SULFATE OR METALSULFATE GROUP AND C) A SUBSTITUENT GROUPS ON THE RING | UNIVERSITY OF TOLEDO | 2004-06-01 | — | — | US | disclosed |
| WO-2004039843-A1 | IMMUNOGLOBULIN G BINDING POCKET | AMERSHAM BIOSCIENCES AB (SE) | 2004-05-13 | — | — | WO | disclosed |
| US-20020052408-A1 | Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-05-02 | — | — | US | disclosed |
| WO-2002004411-A1 | METHODS FOR PROTECTION OF STRATIFIED SQUAMOUS EPITHELIUM AGAINST INJURY BY NOXIOUS SUBSTANCES AND NOVEL AGENTS FOR USE THEREFOR | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2002-01-17 | — | — | WO | disclosed |
| US-4255152-A | USING A DISPERSE DYE, WATER, AND AN ADDUCT OF ETHYLENE, PROPYLENE, OR STYRENE OXIDE AND A CYCLIC-SUBSTITUTED PHENOL; LEVELLING | CIBA-GEIGY CORPORATION (US) | 1981-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200102323-A1 | ACC INHIBITORS AND USES THEREOF | ACACA, ACACB, ACAT2 | SLC6A4 4169/4885GSR 1846/4885SLC6A2 3767/4885 |
| US-20060014735-A1 | Use of urea variants as affinity ligands | IGLV6-57, FCGR2A, FCGR3B | SLC6A4 3931/4885GSR 4317/4885SLC6A2 3363/4885 |
| US-10472374-B2 | ACC inhibitors and uses thereof | ACACA, ACACB, ACAT2 | SLC6A4 4169/4885GSR 1846/4885SLC6A2 3767/4885 |
| US-20020052408-A1 | Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor | HRH2, NR1H4, NCEH1 | SLC6A4 2074/4885GSR 637/4885SLC6A2 2815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.